Dr Patrick Sommer > CMS von Erlach Partners Ltd. > Zurich, Switzerland > Lawyer Profile

CMS von Erlach Partners Ltd.
Dreikönigstrasse 7
PO Box 8022 Zurich
Switzerland
Patrick Sommer photo

Work Department

Competition & EU, Life Sciences & Healthcare

Position

Partner

Career

Dr Patrick Sommer is Co-Head of the CMS Competition & EU Group. In this position, he jointly leads an international team of more than 170 competition lawyers.

Patrick Sommer focuses on competition law, corporate law and M&A.

Patrick Sommer has graduated from the University of St.Gallen in 1987 and was admitted to the bar in 1989. He has written his doctoral thesis on the relationship of Switzerland to the European Union and completed postgraduate studies at the Collège d’Europe in Brugues with the H.E.E. diploma. He then worked for seven years in the legal department of a Swiss multinational group where he has been promoted to the offices of General Counsel and Secretary of the Board of Directors.

In 2000 Patrick Sommer joined CMS and is a partner since 2002.

Languages

German, English, French

Memberships

Zurich and Swiss Bar Association, Studienvereinigung Kartellrecht, International advisory board of the “St. Galler Internationales Kartellrechtsforum”

Education

1989 – Bar admission
1987 – Law studies at the University of St. Gallen

Lawyer Rankings

Switzerland > Healthcare and life sciences

CMS von Erlach Partners Ltd. houses a broad offering which notably acts for Bayer, Eli Lilly, and Unilabs, often leveraging its international network of offices. The team also handles advertising-focused proceedings and cross-border acquisitions. Team co-leads Patrick Sommer routinely advises on M&A and administrative proceedings concerning antitrust pricing issues, and Christoph Willi is well-equipped to handle series financing matters and patent portfolio management mandates.

Switzerland > Competition

A team that is noted for its ‘very good business acumen’, CMS von Erlach Partners Ltd. provides its clients with a one stop shop for competition issues, and demonstrates substantive strengths within the pharmaceutical, construction, technology, and financial services sectors; the group is able to draw upon its global network to operate for multinational corporations in the competition sphere. Three key players helm the group: ‘outstanding’ Marquard Christen, who handles a significant volume of investigations, enforcement actions, and appeals, Patrick Sommer, who is well-positioned to advise on issues arising from heavily regulated sectors such as pharmaceuticals, and Pascal Favre, a capable practitioner in the context of merger controls, antitrust appeals, and internal investigations. Simone Brauchbar Birkhäuser is another name to note, pairing her competition and IP knowledge to advise a varied range of clients.